Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Method for screening prophylactic or therapeutic agents for diseases caused by interleukin 6, interleukin 13, TNF, G-CSF, CXCL1, CXCL2, or CXCL5 and agent for the prevention or treatment of diseases caused by interleukin 6, interleukin 13, TNF, G-CSF, CXCL1, CXCL2, or CXCL5

Method for screening prophylactic or therapeutic agents for diseases caused by interleukin 6, interleukin 13, TNF, G-CSF, CXCL1, CXCL2, or CXCL5 and agent for the prevention or treatment of diseases caused by interleukin 6, interleukin 13, TNF, G-CSF, CXCL1, CXCL2, or CXCL5

US Patent 11279935 · Granted Mar 22, 2022

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Control device for non-excitation-actuated electromagnetic brake, multi-brake sy2023
Nucleic acid inhibiting expression of the MEX3B gene, MEX3B gene expression inhi2022
Nucleic acid inhibiting expression of the MEX3B gene, MEX3B gene expression inhi2022
Nucleic acid inhibiting expression of the MEX3B gene, MEX3B gene expression inhi2022
Communication device2013
Computer-readable recording medium where document management program is recorded2011
sFRP expression enhancing agent2010
Anti-BAMBI antibody and diagnostic or remedy for colon cancer and liver cancer2009
Apoptosis-inducing gene and utilization of the same2008
Action record support program, system, device, and method2008
β-catenin nuclear localized protein2008
Colon cancer metastasis inhibitor2007